With effect from June 15, 2026, the subscription rights in Annexin Pharmaceuticals AB will be traded on First North Growth Market. Trading will continue up until and including June 29, 2026.
With effect from June 15, 2026, the paid subscription shares in Annexin Pharmaceuticals AB will be traded on First North Growth Market. Trading will continue until and including July 17, 2026.
For further information concerning this exchange notice please contact Issuer Surveillance, telephone 46 8 405 70 50, or iss@nasdaq.com
Nasdaq Stockholm AB
| Instrument: | Subscription rights |
| Short name: | ANNX TR |
| Clearing: | Bilateral settlement at Euroclear Sweden |
| ISIN code: | SE0029300888 |
| Order book ID: | 519109 |
| Market Segment: | First North STO |
| Tick Size: | MiFID II tick size table |
With effect from June 15, 2026, the paid subscription shares in Annexin Pharmaceuticals AB will be traded on First North Growth Market. Trading will continue until and including July 17, 2026.
| Instrument: | Paid subscription shares |
| Short name: | ANNX BTA |
| Clearing: | Bilateral settlement at Euroclear Sweden |
| ISIN code: | SE0029300896 |
| Order book ID: | 519108 |
| Market Segment: | First North STO |
| Tick Size: | MiFID II tick size table |
For further information concerning this exchange notice please contact Issuer Surveillance, telephone 46 8 405 70 50, or iss@nasdaq.com
Nasdaq Stockholm AB
© 2026 GlobeNewswire
